Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInterest Coverage RatioInvested CapitalMarket CapitalizationNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on SalesTimes Interest Earned

Taysha Gene Therapies (TSHA) Times Interest Earned: 2022-2025

Historic Times Interest Earned for Taysha Gene Therapies (TSHA) over the last 4 years, with Sep 2025 value amounting to -$2,268.

  • Taysha Gene Therapies' Times Interest Earned fell 110.20% to -$2,268 in Q3 2025 from the same period last year, while for Sep 2025 it was -$1,399, marking a year-over-year decrease of 1163.99%. This contributed to the annual value of -$896.66 for FY2024, which is 6086.57% down from last year.
  • Per Taysha Gene Therapies' latest filing, its Times Interest Earned stood at -$2,268 for Q3 2025, which was down 44.14% from -$1,574 recorded in Q2 2025.
  • Taysha Gene Therapies' 5-year Times Interest Earned high stood at -$11.05 for Q3 2023, and its period low was -$2,268 during Q3 2025.
  • Over the past 3 years, Taysha Gene Therapies' median Times Interest Earned value was -$838.97 (recorded in 2024), while the average stood at -$785.86.
  • Per our database at Business Quant, Taysha Gene Therapies' Times Interest Earned soared by 83.69% in 2023 and then slumped by 9,668.19% in 2024.
  • Over the past 4 years, Taysha Gene Therapies' Times Interest Earned (Quarterly) stood at -$41.35 in 2022, then soared by 44.90% to -$22.79 in 2023, then crashed by 3,876.23% to -$906 in 2024, then crashed by 110.20% to -$2,268 in 2025.
  • Its Times Interest Earned stands at -$2,268 for Q3 2025, versus -$1,574 for Q2 2025 and -$1,127 for Q1 2025.